Literature DB >> 25410456

Promising treatments for neuropathic pain.

Pedro Schestatsky1, Liliane Vidor2, Pablo Brea Winckler1, Tatiane Gomes de Araújo2, Wolnei Caumo3.   

Abstract

In the last few years the understanding of mechanisms and, consequently, the diagnosis of neuropathic pain (NP) has becoming progressively clearer in clinical practice. However, the treatment of such condition remains challenging so far. One of the reasons for such difficulty is the diversity of mechanisms involved in NP generation and its persistency. In the present review we discuss several treatment modalities for NP that are scantily applied in daily clinical practice. For that, we collected positive clinical evidence of unusual and SECS (Safe, Easy, Cheap, and Sensible) approaches for NP. The aim of this review is not to establish the "state of the art" or rigid guidelines for NP treatment. In a different way, we only want bring new possibilities of treatment to the readers and also to motivate investigators to confirm those positive preliminary but promising results for NP reliev.

Entities:  

Mesh:

Year:  2014        PMID: 25410456     DOI: 10.1590/0004-282x20140157

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  9 in total

1.  Pharmacokinetic and pharmacodynamic evaluation of Solid self-nanoemulsifying delivery system (SSNEDDS) loaded with curcumin and duloxetine in attenuation of neuropathic pain in rats.

Authors:  Bimlesh Kumar; Sachin Kumar Singh; T Prakash; Amit Bhatia; Monica Gulati; Varun Garg; Narendra Kumar Pandey; Saurabh Singh; Indu Melkani
Journal:  Neurol Sci       Date:  2020-09-03       Impact factor: 3.307

2.  Picroside II Attenuates CCI-Induced Neuropathic Pain in Rats by Inhibiting Spinal Reactive Astrocyte-Mediated Neuroinflammation Through the NF-κB Pathway.

Authors:  Xiaolian Nong; Yuyan Lan
Journal:  Neurochem Res       Date:  2018-04-18       Impact factor: 3.996

Review 3.  Optogenetics: Therapeutic spark in neuropathic pain.

Authors:  Kang Liu; Long Wang
Journal:  Bosn J Basic Med Sci       Date:  2019-11-08       Impact factor: 3.363

Review 4.  Emerging Treatments for Neuropathic Pain.

Authors:  Bruno L Pessoa; Gabriel Escudeiro; Osvaldo J M Nascimento
Journal:  Curr Pain Headache Rep       Date:  2015-12

5.  Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain.

Authors:  Jun Tang; Chao Zhu; Zhi-hong Li; Xiao-yu Liu; Shu-kai Sun; Ting Zhang; Zhuo-jing Luo; Hui Zhang; Wei-yan Li
Journal:  J Neuroinflammation       Date:  2015-03-25       Impact factor: 8.322

6.  Normalizing JMJD6 Expression in Rat Spinal Dorsal Horn Alleviates Hyperalgesia Following Chronic Constriction Injury.

Authors:  Cheng Mo; Mengyuan Xu; Cen Wen; Ruimin Chang; Changsheng Huang; Wangyuan Zou; Xiaoyan Zhu; Qulian Guo
Journal:  Front Neurosci       Date:  2018-08-07       Impact factor: 4.677

7.  Correlation of TGN-020 with the analgesic effects via ERK pathway activation after chronic constriction injury.

Authors:  Liang Zhao; Dan Li; Nan Liu; Lu Liu; Zhuo Zhang; Chao Gao; Hitoshi Kawano; Fang-Yuan Zhou; Hong-Peng Li
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

Review 8.  The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation.

Authors:  Wenbin Wan; Lan Cao; Ramin Khanabdali; Bill Kalionis; Xiantao Tai; Shijin Xia
Journal:  J Immunol Res       Date:  2016-05-18       Impact factor: 4.818

9.  Neuropathic Pain Treatment: Still a Challenge.

Authors:  Osvaldo J M Nascimento; Bruno L Pessoa; Marco Orsini; Pedro Ribeiro; Eduardo Davidovich; Camila Pupe; Pedro Moreira Filho; Ricardo Menezes Dornas; Lucas Masiero; Juliana Bittencourt; Victor Hugo Bastos
Journal:  Neurol Int       Date:  2016-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.